Caxton Associates (New York)’s Cerence CRNC Stock Holding History
Bought
Maintained
Sold
Other funds holding CRNC
VBA
CCPM
ACM
Caxton Associates (New York)'s CRNC Position: Q1 2023 in Review
Caxton Associates (New York) sold out of Cerence (CRNC) in Q1 2023, closing a stake of 21,379 shares — an estimated $396K sold.
Caxton Associates (New York) first reported a position in CRNC in Q1 2021 and held it in 3 quarters. The position peaked at $412K in Q3 2022. 228 funds tracked by Wall St. Rank hold CRNC as of Q1 2023.
- Caxton Associates (New York) reported no remaining Cerence position as of Q1 2023 after selling out during the quarter.
- Caxton Associates (New York) sold 21,379 Cerence shares in Q1 2023, an estimated $396K.
- Caxton Associates (New York) first reported a position in Cerence in Q1 2021 and held it in 3 quarters.
- Caxton Associates (New York)'s Cerence position peaked at $412K in Q3 2022.
- 228 funds tracked by Wall St. Rank held Cerence as of Q1 2023.
Based on Caxton Associates (New York)'s 13F filing for Q1 2023, filed 15 May 2023.